• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Whitmore Bradford T

    9/3/24 4:46:24 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ULBI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    WHITMORE BRADFORD T

    (Last) (First) (Middle)
    5215 OLD ORCHARD ROAD
    SUITE 620

    (Street)
    SKOKIE IL 60077

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ULTRALIFE CORP [ ULBI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    09/03/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 205,915(4) D
    Common Stock 1,020,927 I(1) By Whitmore Holdings, LLC
    Common Stock 4,452,283 I(2) By SUNRAY I, LLC
    Common Stock 518,616 I(3) By Grace Brothers, LP
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares.
    2. As manager of SUNRAY I, LLC, Bradford T. Whitmore is the indirect beneficial owner of these shares.
    3. As manager of Whitmore Holdings, LLC, which is the sole General Partner of Grace Brothers, LP, Bradford T. Whitmore is the indirect beneficial owner of these shares.
    4. The reporting person no longer has a reportable beneficial interest in 3,272 shares of Common Stock owned by his daughter and included in the reporting person's prior ownership reports.
    Bradford T. Whitmore 09/03/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ULBI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ULBI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ULBI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Robert W. Shaw bought $9,922 worth of Common Stock; $.10 par value (1,750 units at $5.67), increasing direct ownership by 3% to 71,000 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    11/26/25 9:58:19 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Director Whitmore Bradford T bought $267,915 worth of shares (53,900 units at $4.97) (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    11/21/25 4:01:02 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Manna Michael Edward bought $9,933 worth of Common Stock; $.10 par value (2,000 units at $4.97), increasing direct ownership by 9% to 24,874 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    11/19/25 3:15:34 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ultralife Corporation Reports Third Quarter Results

    NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem, sales of $36.6 million increased 2.5%Gross profit of $9.6 million, or 22.2% of revenue, compared to $8.7 million, or 24.3% of revenue, for the third quarter of 2024Operating loss of $1.0 million, reflecting one-time non-recurring costs of $1.1 million, including a $.5 million provision to close our Calgary facility, compared to operating income of $0.5 million for the third quarter of 2024GAAP EP

    11/18/25 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation to Report Third Quarter Results on November 18, 2025

    NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on November 18, 2025.   Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call:   https://register-conf.media-server.com/register/BI0301fd92021249ef830e0c9c7b

    11/13/25 4:30:00 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation Files Form 12b-25 Notification of Late Filing

    NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025. As previously disclosed, on October 31, 2024, Ultralife completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. ("Electrochem") from Integer Holdings Corporation ("Integer"). During the third quarter of 2025, the transition services agreement between Ultralife and Integer under which Integer maintained the books and records of Electrochem on its information systems concluded, and

    11/7/25 4:30:00 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    SEC Filings

    View All

    Ultralife Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - ULTRALIFE CORP (0000875657) (Filer)

    11/18/25 7:30:23 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 10-Q filed by Ultralife Corporation

    10-Q - ULTRALIFE CORP (0000875657) (Filer)

    11/17/25 5:26:48 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form NT 10-Q filed by Ultralife Corporation

    NT 10-Q - ULTRALIFE CORP (0000875657) (Filer)

    11/7/25 2:14:55 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Robert W. Shaw bought $9,922 worth of Common Stock; $.10 par value (1,750 units at $5.67), increasing direct ownership by 3% to 71,000 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    11/26/25 9:58:19 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Director Whitmore Bradford T bought $267,915 worth of shares (53,900 units at $4.97) (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    11/21/25 4:01:02 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Manna Michael Edward bought $9,933 worth of Common Stock; $.10 par value (2,000 units at $4.97), increasing direct ownership by 9% to 24,874 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    11/19/25 3:15:34 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Benchmark initiated coverage on Ultralife with a new price target

    Benchmark initiated coverage of Ultralife with a rating of Buy and set a new price target of $12.00

    3/26/21 8:30:50 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    The Benchmark Company initiated coverage on Ultralife with a new price target

    The Benchmark Company initiated coverage of Ultralife with a rating of Buy and set a new price target of $12.00

    3/26/21 7:38:12 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Financials

    Live finance-specific insights

    View All

    Ultralife Corporation Reports Third Quarter Results

    NEWARK, N.Y., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the third quarter ended September 30, 2025 with the following results: Sales of $43.4 million increased 21.5% from $35.7 million for the third quarter of 2024; excluding Electrochem, sales of $36.6 million increased 2.5%Gross profit of $9.6 million, or 22.2% of revenue, compared to $8.7 million, or 24.3% of revenue, for the third quarter of 2024Operating loss of $1.0 million, reflecting one-time non-recurring costs of $1.1 million, including a $.5 million provision to close our Calgary facility, compared to operating income of $0.5 million for the third quarter of 2024GAAP EP

    11/18/25 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation to Report Third Quarter Results on November 18, 2025

    NEWARK, N.Y., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) will report its third quarter results for the period ended September 30, 2025 before the market opens on Tuesday, November 18, 2025. Ultralife's Management will also host an investor conference call and simultaneous webcast at 8:30 AM ET on November 18, 2025.   Please see the call-in procedures which follow below. NOTE TO THOSE PLANNING TO PARTICIPATE BY PHONE: To ensure a fast and reliable connection to our investor conference call, we require participants dialing in by phone to pre-register using this link prior to the call:   https://register-conf.media-server.com/register/BI0301fd92021249ef830e0c9c7b

    11/13/25 4:30:00 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation Reports Second Quarter Results

    NEWARK, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating results for the second quarter ended June 30, 2025 with the following results: Sales of $48.6 million increased 13.0% from $43.0 million for the second quarter of 2024; excluding Electrochem, sales of $39.3 million declined 8.7% due to a 57.2% decrease in Communications Systems salesGross profit of $11.6 million, or 23.9% of revenue, compared to $11.6 million, or 26.9% of revenue, for the second quarter of 2024Operating income of $2.3 million, including one-time non-recurring costs and purchase accounting adjustments of $0.3 million, compared to $3.9 million for the second quarter of 202

    8/7/25 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Leadership Updates

    Live Leadership Updates

    View All

    Ultralife Corporation Expands Leadership Team to Drive Rapid Growth Plans

    NEWARK, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) today announced the appointment of Jeffrey Luke as Chief Marketing Officer and James Pope as Senior Vice President - Sales & Business Development, Battery & Energy Products, effective January 6, 2025. As Chief Marketing Officer, Jeff will be responsible for reframing our corporate and brand strategies, providing alignment and accountability throughout the global organization. He will collaborate closely with our sales and engineering teams to develop and execute effective go-to-market strategies, ensuring that Ultralife's products and solutions meet the evolving needs of our customers. Jeff brings over two

    1/6/25 7:00:00 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Ultralife Corporation Names Michael E. Manna President & CEO

    NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation ("Ultralife" or the "Company") (NASDAQ:ULBI) has appointed Michael E. Manna as the Company's President & CEO and as a member of the Board of Directors effective immediately to replace Michael D. Popielec who is leaving the Company. Mr. Popielec will remain with Ultralife as an employee for a sixty-day period ending January 20, 2023 in an advisory role to ensure a smooth leadership transition. In addition to his new role, Mike Manna will retain his leadership position for the Company's Battery & Energy Products segment which he held prior to his appointment as President & CEO. "Over the past twe

    11/22/22 4:30:00 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ULBI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Ultralife Corporation

    SC 13D/A - ULTRALIFE CORP (0000875657) (Subject)

    9/3/24 4:15:14 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Ultralife Corporation

    SC 13G - ULTRALIFE CORP (0000875657) (Subject)

    2/14/24 1:50:40 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G/A filed by Ultralife Corporation (Amendment)

    SC 13G/A - ULTRALIFE CORP (0000875657) (Subject)

    2/9/24 9:59:17 AM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous